Also I think you have to consider the time factor for big pharma.
AD214 has taken a decade to get to this point. Let's say 3 years have been wasted along the way for various reasons, but that's still 7 years from discovery to end of Phase 1.
With patents running out and an ever increasing need to keep the revenue streams ticking along, for an upfront payment of $45m big pharma can save themselves not only the cost of developing the drug ($45m to date), but also the 7 years of development, not to mention mitigation of the risk involved, as there is no guarantee that even after 7 years they could get a drug ready to start phase 2, with a safety profile and novel mode of action in a multi billion dollar market.
Therefore with that in mind I don't think the best light to view the upfront is against current MC, I believe it's against the time and risk mitigation for big pharma in getting an alternative drug to this stage of development, therefore in that light, a $45m upfront and another $45m for phase II trials, so under $100m gets you a drug that in three years could be starting a Phase III in a multi billion dollar indication with little or no competition
- Forums
- ASX - By Stock
- Ann: Positive AD-214 Phase I extension study results
Also I think you have to consider the time factor for big...
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
-0.001(4.17%) |
Mkt cap ! $12.26M |
Open | High | Low | Value | Volume |
2.5¢ | 2.5¢ | 2.3¢ | $2.466K | 102.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 635388 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 302763 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 635388 | 0.023 |
1 | 10000 | 0.022 |
4 | 1327615 | 0.021 |
5 | 951797 | 0.020 |
2 | 1028500 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 302763 | 4 |
0.027 | 370833 | 1 |
0.029 | 335889 | 2 |
0.030 | 600000 | 2 |
0.031 | 7039 | 1 |
Last trade - 15.02pm 15/05/2024 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online